Ketones block amyloid entry and improve cognition in an Alzheimer's model

[1]  T. Vanitallie,et al.  A new way to produce hyperketonemia: Use of ketone ester in a case of Alzheimer's disease , 2015, Alzheimer's & Dementia.

[2]  E. Verdin,et al.  β-hydroxybutyrate: much more than a metabolite. , 2014, Diabetes research and clinical practice.

[3]  Patrick Walsh,et al.  Differences between amyloid-β aggregation in solution and on the membrane: insights into elucidation of the mechanistic details of Alzheimer's disease. , 2014, Chemical Society reviews.

[4]  E. Reiman,et al.  Pituitary adenylate cyclase-activating polypeptide protects against β-amyloid toxicity , 2014, Neurobiology of Aging.

[5]  Xinglong Wang,et al.  Oxidative stress and mitochondrial dysfunction in Alzheimer's disease. , 2014, Biochimica et biophysica acta.

[6]  Lothar A. Blatter,et al.  Role of β-hydroxybutyrate, its polymer poly-β-hydroxybutyrate and inorganic polyphosphate in mammalian health and disease , 2014, Front. Physiol..

[7]  H. Chen,et al.  The β-hydroxybutyrate receptor HCA2 activates a neuroprotective subset of macrophages , 2014, Nature Communications.

[8]  E. Giralt,et al.  Reelin delays amyloid-beta fibril formation and rescues cognitive deficits in a model of Alzheimer’s disease , 2014, Nature Communications.

[9]  Robert W. Peoples,et al.  Nature of the neurotoxic membrane actions of amyloid-β on hippocampal neurons in Alzheimer's disease , 2014, Neurobiology of Aging.

[10]  S. Coons,et al.  Association of amyloid burden, brain atrophy and memory deficits in aged apolipoprotein ε4 mice. , 2014, Current Alzheimer research.

[11]  J. Fantini,et al.  Bexarotene blocks calcium-permeable ion channels formed by neurotoxic Alzheimer's β-amyloid peptides. , 2014, ACS chemical neuroscience.

[12]  Noo Li Jeon,et al.  β‐Amyloid is transmitted via neuronal connections along axonal membranes , 2014, Annals of neurology.

[13]  E. Wirrell,et al.  Ketogenic diet in Cdkl5-related epilepsy , 2013, Journal of the Neurological Sciences.

[14]  E. Reiman,et al.  Pituitary adenylate cyclise-activating polypeptide (PACAP) protects against beta-amyloid toxicity and potentiates mitochondrial function , 2013, Alzheimer's & Dementia.

[15]  M. Mattson,et al.  A ketone ester diet exhibits anxiolytic and cognition-sparing properties, and lessens amyloid and tau pathologies in a mouse model of Alzheimer's disease , 2013, Neurobiology of Aging.

[16]  R. Yasuda,et al.  Centaurin-α1-Ras-Elk-1 Signaling at Mitochondria Mediates β-Amyloid-Induced Synaptic Dysfunction , 2013, The Journal of Neuroscience.

[17]  Eric Verdin,et al.  Suppression of Oxidative Stress by β-Hydroxybutyrate, an Endogenous Histone Deacetylase Inhibitor , 2013, Science.

[18]  D. Holtzman,et al.  Alzheimer disease in 2020. , 2012, Cold Spring Harbor perspectives in medicine.

[19]  R. Kimura,et al.  Acute Exposure to the Mitochondrial Complex I Toxin Rotenone Impairs Synaptic Long‐Term Potentiation in Rat Hippocampal Slices , 2012, CNS neuroscience & therapeutics.

[20]  R. Mayeux,et al.  Epidemiology of Alzheimer disease. , 2012, Cold Spring Harbor perspectives in medicine.

[21]  A. Reichert,et al.  From Mitochondrial Dysfunction to Amyloid Beta Formation: Novel Insights into the Pathogenesis of Alzheimer’s Disease , 2012, Molecular Neurobiology.

[22]  W. K. Cullen,et al.  Alzheimer’s disease Aβ assemblies mediating rapid disruption of synaptic plasticity and memory , 2012, Molecular Brain.

[23]  L. Mucke,et al.  Neurotoxicity of amyloid β-protein: synaptic and network dysfunction. , 2012, Cold Spring Harbor perspectives in medicine.

[24]  Kevin W Eliceiri,et al.  NIH Image to ImageJ: 25 years of image analysis , 2012, Nature Methods.

[25]  K. Renner,et al.  Mitochondrial Dysfunction—A Pharmacological Target in Alzheimer's Disease , 2012, Molecular Neurobiology.

[26]  R. Nussinov,et al.  Antimicrobial properties of amyloid peptides. , 2012, Molecular pharmaceutics.

[27]  J. Galvin,et al.  Use of medical foods and nutritional approaches in the treatment of Alzheimer's disease. , 2012, Clinical practice.

[28]  D. Clegg,et al.  Dietary ketosis enhances memory in mild cognitive impairment , 2012, Neurobiology of Aging.

[29]  M. Staufenbiel,et al.  Transgenic Expression of Intraneuronal Aβ42 But Not Aβ40 Leads to Cellular Aβ Lesions, Degeneration, and Functional Impairment without Typical Alzheimer's Disease Pathology , 2012, The Journal of Neuroscience.

[30]  P. Reddy,et al.  Impaired mitochondrial biogenesis, defective axonal transport of mitochondria, abnormal mitochondrial dynamics and synaptic degeneration in a mouse model of Alzheimer's disease. , 2011, Human molecular genetics.

[31]  Josemir W Sander,et al.  The ketogenic and related diets in adolescents and adults—A review , 2011, Epilepsia.

[32]  J. Ainge,et al.  Mitochondrial β-amyloid in Alzheimer's disease. , 2011, Biochemical Society transactions.

[33]  W. Klein,et al.  Intraneuronal amyloid β oligomers cause cell death via endoplasmic reticulum stress, endosomal/lysosomal leakage, and mitochondrial dysfunction in vivo , 2011, Journal of neuroscience research.

[34]  M. Lambert,et al.  Intraneuronal amyloid-beta oligomers cause cell death via endoplasmic reticulum stress, endosomal/lysosomal leakage, and mitochondrial dysfunction in vivo , 2011, Alzheimer's & Dementia.

[35]  D. Holtzman,et al.  Critical Role of Astroglial Apolipoprotein E and Liver X Receptor-α Expression for Microglial Aβ Phagocytosis , 2011, The Journal of Neuroscience.

[36]  D. Selkoe,et al.  The presence of sodium dodecyl sulphate-stable Abeta dimers is strongly associated with Alzheimer-type dementia. , 2010, Brain : a journal of neurology.

[37]  F. Schweizer,et al.  Ubiquitination Acutely Regulates Presynaptic Neurotransmitter Release in Mammalian Neurons , 2010, The Journal of Neuroscience.

[38]  Julie A. Harris,et al.  Many Neuronal and Behavioral Impairments in Transgenic Mouse Models of Alzheimer's Disease Are Independent of Caspase Cleavage of the Amyloid Precursor Protein , 2010, The Journal of Neuroscience.

[39]  F. Heppner,et al.  Formation and maintenance of Alzheimer's disease β-amyloid plaques in the absence of microglia , 2009, Nature Neuroscience.

[40]  L. Jungbauer,et al.  Preparation of fluorescently‐labeled amyloid‐beta peptide assemblies: the effect of fluorophore conjugation on structure and function , 2009, Journal of molecular recognition : JMR.

[41]  K. Jacobson,et al.  Small molecule blockers of the Alzheimer Aβ calcium channel potently protect neurons from Aβ cytotoxicity , 2009, Proceedings of the National Academy of Sciences.

[42]  David P. Carney,et al.  Biochemical characterization, localization, and tissue distribution of the longer form of mouse SIRT3 , 2009, Protein science : a publication of the Protein Society.

[43]  Michael P. Murphy,et al.  How mitochondria produce reactive oxygen species , 2008, The Biochemical journal.

[44]  J. Rho,et al.  Oxidative impairment of hippocampal long‐term potentiation involves activation of protein phosphatase 2A and is prevented by ketone bodies , 2008, Journal of neuroscience research.

[45]  Joseph P. Huston,et al.  The pharmacology, neuroanatomy and neurogenetics of one-trial object recognition in rodents , 2007, Neuroscience & Biobehavioral Reviews.

[46]  L. Mucke,et al.  Reducing Endogenous Tau Ameliorates Amyloid ß-Induced Deficits in an Alzheimer's Disease Mouse Model , 2007, Science.

[47]  M. Beal,et al.  Mitochondrial dysfunction and oxidative stress in neurodegenerative diseases , 2006, Nature.

[48]  Rick A Bevins,et al.  Object recognition in rats and mice: a one-trial non-matching-to-sample learning task to study 'recognition memory' , 2006, Nature Protocols.

[49]  Hai Lin,et al.  Amyloid ion channels: a common structural link for protein-misfolding disease. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[50]  Robert S. Balaban,et al.  Mitochondria, Oxidants, and Aging , 2005, Cell.

[51]  L. Mucke,et al.  Aggressive amyloidosis in mice expressing human amyloid peptides with the Arctic mutation , 2004, Nature Medicine.

[52]  Rustam Azimov,et al.  The channel hypothesis of Alzheimer’s disease: current status , 2002, Peptides.

[53]  Kang Hu,et al.  High-Level Neuronal Expression of Aβ1–42 in Wild-Type Human Amyloid Protein Precursor Transgenic Mice: Synaptotoxicity without Plaque Formation , 2000, The Journal of Neuroscience.

[54]  K. Clarke,et al.  D-beta-hydroxybutyrate protects neurons in models of Alzheimer's and Parkinson's disease. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[55]  B. Kagan,et al.  Amyloid peptide channels: Blockade by zinc and inhibition by Congo red (amyloid channel block) , 2000, Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis.

[56]  R. Nicoll,et al.  Plaque-independent disruption of neural circuits in Alzheimer's disease mouse models. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[57]  W. K. Cullen,et al.  Block of LTP in rat hippocampus in vivo by β‐amyloid precursor protein fragments , 1997 .

[58]  I. Ferreira,et al.  Impaired transcription in Alzheimer's disease: key role in mitochondrial dysfunction and oxidative stress. , 2013, Journal of Alzheimer's disease : JAD.

[59]  F. Gunn-Moore,et al.  Is amyloid binding alcohol dehydrogenase a drug target for treating Alzheimer's disease? , 2013, Current Alzheimer research.

[60]  P. Barberger‐Gateau,et al.  Brain fuel metabolism, aging, and Alzheimer's disease. , 2011, Nutrition.

[61]  S. Coons,et al.  Deficits in spatial learning and memory is associated with hippocampal volume loss in aged apolipoprotein E4 mice. , 2011, Journal of Alzheimer's disease : JAD.

[62]  Nutrition & Metabolism BioMed Central Review Targeting energy metabolism in brain cancer: review and , 2005 .